Site updated at Wednesday, 22 June 2016

Living with Dementia

Immune Globulin

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   

Living with Dementia

university of gothenburg1 - alzheimer's disease biomarkers1 - frontotemporal degeneration1 - education1 - early-onset familial ad1 - against alzheimer's1 - deep-brain stimulation3 - american delirium society1 - carotid ultrasound1 - dementia friends1 - tau proteins1 - single-infarct dementia1 - gene therapy1 - mood changes1 - movement tremors1 - morphometry1 - broken bones1 - invisible disease1 - dementia care program1 - microhemmorhage1 - pre-senile dementia1 - acute excitement1 - apolipoprotein1 - glucose metabolism2 - temporal orientation1 - neurotrophic factor1 - psychotic symptoms1 - dementia in elderly1 - memory skills1 - transient ischaemic attack1 -